Tech Company Financing Transactions

Compound Therapeutics Funding Round

Atlas Venture, Flagship Pioneering and Polaris Partners participated in a $12 million Series A venture round for Compound Therapeutics. The financing round was announced on 5/28/2003.

Transaction Overview

Announced On
5/28/2003
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors

Atlas Venture (Lead Investor) (Jean-Franois Formela)

Flagship Pioneering (Lead Investor) (Noubar Afeyan)

Polaris Partners (Lead Investor) (Terry McGuire)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
100 Beaver Street
Waltham, MA 02453
USA
Email Address
Overview
Compound Therapeutics is a product discovery and development company creating the next generation of biotherapeutics using three proprietary technologies.
Profile
Compound Therapeutics LinkedIn Company Profile
Social Media
Compound Therapeutics Company Twitter Account
Company News
Compound Therapeutics News
Facebook
Compound Therapeutics on Facebook
YouTube
Compound Therapeutics on YouTube

Management Team

Title
Name
Email & Social
President
John Edwards
  John Edwards LinkedIn Profile  John Edwards Twitter Account  John Edwards News  John Edwards on Facebook
Vice President
Sharon Cload
  Sharon Cload LinkedIn Profile  Sharon Cload Twitter Account  Sharon Cload News  Sharon Cload on Facebook
VP - Human Resources
Erin Lanciani
  Erin Lanciani LinkedIn Profile  Erin Lanciani Twitter Account  Erin Lanciani News  Erin Lanciani on Facebook
VP - Manufacturing
Alex Chu
  Alex Chu LinkedIn Profile  Alex Chu Twitter Account  Alex Chu News  Alex Chu on Facebook
VP - Product Management
Kelledy Manson
  Kelledy Manson LinkedIn Profile  Kelledy Manson Twitter Account  Kelledy Manson News  Kelledy Manson on Facebook
VP - R & D
Eric Furfine
  Eric Furfine LinkedIn Profile  Eric Furfine Twitter Account  Eric Furfine News  Eric Furfine on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/28/2003: Cornice venture capital transaction
Next: 5/29/2003: Cellerant Therapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary